RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal Syndrome
NCT04273750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2020-02-18
Summary
Hepatorenal syndrome is a life-threatening medical condition and a serious complication of advanced liver scarring (cirrhosis). It consists of a deterioration of the function of the kidneys caused by a severe alteration in the circulation (blood flow to the kidneys) due to liver cirrhosis. Only around half of the patients respond to treatment which consists of intravenous medication. Moreover, the adrenal glands, which are located on the kidneys, also suffer an alteration in the blood flow leading to deterioration in their function as well. Thus, these patients produced less cortisol than needed; this situation is called "relative adrenal insufficiency". Cortisol is an important hormone necessary in extreme situations such as severe diseases. This is a study which will assess the relationship between the presence of adrenal dysfunction and failure to treatment in patients with hepatorenal syndrome.
Conditions
- Liver Cirrhosis
- Acute Kidney Injury
- Hepato-Renal Syndrome
Sponsors & Collaborators
-
University Hospital Plymouth NHS Trust
lead OTHER
Principal Investigators
-
Juan Acevedo, MD · [email protected]
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-05
- Primary Completion
- 2020-02-05
- Completion
- 2020-02-05
Countries
- United Kingdom
Study Locations
More Related Trials
-
Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
NCT04522297 ·Status: COMPLETED ·Phase: NA
-
Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal Hemorrhage
NCT04184934 ·Status: UNKNOWN
-
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
NCT01143246 ·Status: COMPLETED ·Phase: PHASE3
-
Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1
NCT03822091 ·Status: COMPLETED ·Phase: PHASE3
-
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
NCT04460560 ·Status: COMPLETED ·Phase: PHASE3
-
To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure
NCT02573727 ·Status: COMPLETED ·Phase: NA
-
Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis
NCT01932151 ·Status: COMPLETED ·Phase: NA
-
Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome
NCT00734136 ·Status: TERMINATED ·Phase: NA
-
Angiotensin 2 for Hepatorenal Syndrome
NCT04048707 ·Status: WITHDRAWN ·Phase: PHASE2
-
Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study
NCT03092401 ·Status: UNKNOWN
-
Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.
NCT04416282 ·Status: COMPLETED ·Phase: NA
-
Acute-On-Chronic Liver Failure In Cirrhotic Patients
NCT04790435 ·Status: COMPLETED
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients
NCT02434445 ·Status: RECRUITING
-
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
NCT04658407 ·Status: UNKNOWN
-
Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HP
NCT07262515 ·Status: RECRUITING
-
Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis
NCT02307409 ·Status: COMPLETED
-
Hepatic Pseudoaneurysms After Trauma
NCT01938885 ·Status: COMPLETED
-
Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
NCT00089570 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
NCT04806581 ·Status: UNKNOWN ·Phase: PHASE1
-
Short-term Survival in Patients With Severe Alcoholic Hepatitis Treated With Steroid Versus Pentoxifylline
NCT01455337 ·Status: UNKNOWN ·Phase: PHASE3
-
Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage
NCT03846180 ·Status: COMPLETED
-
Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .
NCT03084185 ·Status: UNKNOWN
-
Adrenal Insufficiency in Critical Emergencies in Digestive Diseases
NCT00562445 ·Status: UNKNOWN
-
To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock
NCT02468063 ·Status: COMPLETED ·Phase: NA